Log In
Print
BCIQ
Print
Print this Print this
 

IDX21437

  Manage Alerts
Collapse Summary General Information
Company Idenix Pharmaceuticals Inc.
DescriptionUridine nucleotide analog HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis
Indication DetailsTreat HCV genotypes 1, 2 or 3 infection; Treat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today